Table 2.
Cohort characteristics of the COBRA and COBRA-light groups.
| All patients | COBRA group | COBRA-light group | |
|---|---|---|---|
| N | 35 | 14 | 21 |
| Age, years, median (IQR) | 54 (45–60) | 56 (44–61) | 54 (45–59) |
| Female gender, n (%) | 25 (71) | 9 (64) | 16 (76) |
| DAS at baseline, median (IQR) | 4.0 (3.3–4.6) | 4.0 (3.7–4.6) | 4.0 (3.3–4.5) |
| DAS at T26, median (IQR) | 1.7 (0.8–2.1) | 1.2 (0.4–2.0) | 1.8 (1.0–2.4) |
| DAS at T26 ≤ 2.4, n (%) | 28 (80) | 12 (86) | 16 (76) |
IQR, interquartile range.